Data from the PREFER study—a large, multicenter prospective cohort in Italy—show that while most premenopausal women with early breast cancer opted for GnRHa therapy to protect their ovaries during ...
Allison Aubrey is a Washington-based correspondent for NPR News, where her stories can be heard on Morning Edition and All Things Considered. She has reported extensively on the coronavirus pandemic ...
June 15 (Reuters) - Women preparing for fertility treatment get a series of daily, sometimes uncomfortable, hormone shots to kick their ovaries into overdrive, but a European review of previous ...